Semifluorinated alkane technology brings advantages for topical therapy.
- Published in:
- 2017
- By:
- Publication type:
- Product Review
Works matching DE "NOVALIQ GmbH"
Results: 2
1
2
Novaliq begins Phase 2 trial of Cyclasol for dry eye disease.
- Published in:
- Optometry Times, 2016, v. 8, n. 3, p. 24
- Publication type:
- Article